Cart
sales@molnova.com
GQ-16
CAS No. 870554-67-9
GQ-16( —— )
Catalog No. M27488 CAS No. 870554-67-9
GQ-16 is a partial agonist of PPARγ with a Ki of 160 nM. GQ-16 reduces adipogenic actions and promotes insulin Sensitization without weight gain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | Get Quote |
|
| 10MG | 50 | Get Quote |
|
| 25MG | 110 | Get Quote |
|
| 50MG | 177 | Get Quote |
|
| 100MG | 295 | Get Quote |
|
| 200MG | 444 | Get Quote |
|
| 500MG | 710 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGQ-16
-
NoteResearch use only, not for human use.
-
Brief DescriptionGQ-16 is a partial agonist of PPARγ with a Ki of 160 nM. GQ-16 reduces adipogenic actions and promotes insulin Sensitization without weight gain.
-
DescriptionGQ-16 is a partial agonist of PPARγ with a Ki of 160 nM. GQ-16 reduces adipogenic actions and promotes insulin Sensitization without weight gain.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorSyk
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number870554-67-9
-
Formula Weight418.3
-
Molecular FormulaC19H16BrNO3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (23.91 mM)
-
SMILESCc1ccc(CN(C(/C(/S2)=C/c(cc(cc3)Br)c3OC)=O)C2=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 31, No. 4, 2017.
molnova catalog
related products
-
Tetradecylthioacetic...
Tetradecylthioacetic acid is a synthetic fatty acid with a sulfur substitution in the β-position. This modification renders TTA unable to undergo complete β-oxidation and increases its biological activity, including activation of peroxisome proliferator activated receptors (PPARs) with preference for PPARα.
-
Reglitazar
Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
-
T0070907
T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM.
